SCHEMBL30264759

SCHEMBL30264759

COc1cc2ncnc(N)c2cc1OC1CCN(C(=O)OC(C)(C)C)CC1

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 2/20 0.54
PIK3CA P42336 2/20 0.54
PIK3CB P42338 2/20 0.54
PIK3CG P48736 2/20 0.54
PDE4B Q07343 3/20 0.54
PDE4A P27815 2/20 0.54
PDE4C Q08493 2/20 0.54
PDE4D Q08499 2/20 0.54
EGFR P00533 12/20 0.50
ERBB2 P04626 5/20 0.50
BRAF P15056 1/20 0.49
NSD2 O96028 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29465791 0.88 PIK3CD (0.54) PIK3CDPIK3CAPIK3CBPIK3CGPDE4B
SCHEMBL2453138 0.88 PIK3CD (0.54) PIK3CDPIK3CAPIK3CBPIK3CGPDE4B
SCHEMBL29465790 0.88 PIK3CD (0.54) PIK3CDPIK3CAPIK3CBPIK3CGPDE4B
SCHEMBL665187 0.88 PIK3CD (0.54) PIK3CDPIK3CAPIK3CBPIK3CGPDE4B
SCHEMBL5828984 0.87 EPHA2 (0.50) PIK3CDPIK3CAPIK3CBPIK3CGERBB2
SCHEMBL30264767 0.87 PIK3CD (0.53) PIK3CDPIK3CAPIK3CBPIK3CGPDE4B
SCHEMBL28983513 0.84 PIK3CD (0.49) PIK3CDPIK3CAPIK3CBPIK3CGPDE4B
SCHEMBL29686088 0.84 PIK3CD (0.49) PIK3CDPIK3CAPIK3CBPIK3CGPDE4B
SCHEMBL28983490 0.83 PIK3CD (0.48) PIK3CDPIK3CAPIK3CBPIK3CGPDE4B
SCHEMBL30264797 0.83 PDE10A (0.62) PIK3CDPIK3CAPIK3CBPIK3CGPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4392423-A1 QUINAZOLINE COMPOUNDS FOR TREATMENT OF DISEASE Arthrosi Therapeutics, Inc. (US) 2024-07-03 EP disclosed
WO-2023028054-A1 QUINAZOLINE COMPOUNDS FOR TREATMENT OF DISEASE ARTHROSI THERAPEUTICS, INC. (US) 2023-03-02 WO disclosed